Raj Satkunasivam, MD, MS, FRCSC

Associate Professor of Urology, Academic Institute
Associate Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Raj Satkunasivam is a fellowship-trained urologic oncologist with a focus on minimally invasive and robotic approaches to the treatment of genito-urinary malignancies. His practice includes minimally invasive and robotic surgical techniques for kidney, bladder, prostate, adrenal and testicular cancers. He is the Director of Advanced Laparoscopic and Robotic Surgery at the Houston Methodist Institute for Technology, Innovation, and Education (MITIE).

Dr. Satkunasivam received his medical degree from the University of Toronto and completed his urology residency also at the University of Toronto. He pursued sub-specialty fellowship training in urologic oncology, advanced robotic and laparoscopic surgery at the University of Southern California, where he developed novel techniques for robotic kidney-sparing surgery (partial nephrectomy) and robotic bladder cancer surgery with entirely robotic (intra-corporeal) urinary reconstruction.

Description of Research

Prior to joining Houston Methodist Hospital, Dr. Satkunasivam was an Assistant Professor and Surgeon Investigator at the University of Toronto's Odette Cancer Center at Sunnybrook Hospital. He holds a Master of Science in Health Services Research from the Department of Preventive Medicine, University of Southern California. His research is focused on the clinical epidemiology of genito-urinary malignancies, specifically in identifying novel risk factors, improving individualized risk assessment and in assessing the comparative effectiveness of treatments. His research also examines outcomes and quality of surgical care, and novel strategies to improve the care of complex surgical patients. He is currently an Assistant Professor in the Houston Methodist Academic Institute and a Health Services Researcher in the Center for Outcomes Research at Houston Methodist Hospital.

Areas Of Expertise

Urologic oncology
Publications

A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin-ineligible MIBC: The RAD VACCINE MIBC trial
Satkunasivam, R, Lim, K, Teh, BS, Guzman, J, Zhang, J, Farach, A, Chen, S-H, Wallis, CJD, Efstathiou, E, Esnaola, NF & Sonpavde, GP 2022, , Future Oncology, vol. 18, no. 25, pp. 2771-2781. https://doi.org/10.2217/fon-2022-0380

Localized prostate cancer: An analysis of the CDC Breast and Prostate Cancer Data Quality and Patterns of Care study (CDC PoC-BP)
Celtik, K, Wallis, CJD, Lo, M, Lim, K, Lipscomb, J, Fleming, S, Wu, XC, Anderson, RT, Thompson, TD, Farach, A, Hamilton, AS, Miles, BJ & Satkunasivam, R 2022, , Journal of the Canadian Urological Association, vol. 16, no. 7. https://doi.org/10.5489/cuaj.7580

Association Between Surgeon and Anesthesiologist Sex Discordance and Postoperative Outcomes: A Population-based Cohort Study
Wallis, CJD, Jerath, A, Kaneshwaran, K, Hallet, J, Coburn, N, Wright, FC, Conn, LG, Bischof, D, Covelli, A, Klaassen, Z, Zlotta, AR, Kulkarni, GS, Luckenbaugh, AN, Armstrong, K, Lim, K, Bass, B, Detsky, AS & Satkunasivam, R 2022, , Annals of surgery, vol. 276, no. 1, pp. 81-87. https://doi.org/10.1097/SLA.0000000000005495

Association Between Perioperative Chemotherapy and Survival in Men Undergoing Radical Resection for Primary Urethral Urothelial Carcinoma: An Analysis of the National Cancer Database
Celtik, K, Lim, K, Dursun, F, Xu, J, Klaassen, Z, Zhang, J, Efstathiou, E, Sonpavde, G, Wallis, C & Satkunasivam, R 2022, , Clinical Genitourinary Cancer, vol. 20, no. 3, pp. 244-251. https://doi.org/10.1016/j.clgc.2022.01.011

Comments on Surgeon-Patient Sex Concordance and Postoperative Outcomes-Reply
Wallis, CJD, Jerath, A & Satkunasivam, R 2022, , JAMA Surgery, vol. 157, no. 7, pp. 639-640. https://doi.org/10.1001/jamasurg.2022.0297

Clinical outcomes and patterns of population-based management of urachal carcinoma of the bladder: An analysis of the National Cancer Database
Dursun, F, Lim, K, Svatek, RS, Xu, J, El-Zaatari, ZM, Wenker, EP, Klaassen, ZW, Mansour, AM, Muhammad, T, Efstathiou, E, Sonpavde, GP, Wallis, CJD & Satkunasivam, R 2022, , Cancer Medicine. https://doi.org/10.1002/cam4.4786

Prognostic Impact of Biologically Equivalent Dose in Stereotactic Body Radiation Therapy for Renal Cancer
Tran, KT, Chevli, NC, Messer, JA, Haque, W, Farach, AM, Satkunasivam, R, Zhang, J, Darcourt, J, Lo, SS, Siva, S, Butler, EB & Teh, BS 2021, , International Journal of Radiation Oncology, Biology, Physics, vol. 111, no. 3, pp. e262. https://doi.org/10.1016/j.ijrobp.2021.07.862

DMSA-SPECT: A Novel Approach to Nephron Sparing SBRT for Renal Cell Carcinoma
Chevli, N, Chiang, S, Farach, AM, Haque, W, Satkunasivam, R, Bernicker, EH, Pino, R, Butler, EB & Teh, BS 2021, , Advances in Radiation Oncology, vol. 6, no. 6, 100719. https://doi.org/10.1016/j.adro.2021.100719, https://doi.org/10.1016/j.adro.2021.100719

DMSA-SPECT: A Novel Approach to Nephron Sparing SBRT for Renal Cell Carcinoma
Chevli, N, Chiang, S, Farach, AM, Haque, W, Satkunasivam, R, Bernicker, EH, Pino, R, Butler, EB & Teh, BS 2021, , Advances in Radiation Oncology, vol. 6, no. 6, 100719. https://doi.org/10.1016/j.adro.2021.100719

Dissecting the role of radical cystectomy and urinary diversion in post-operative complications: an analysis using the American College of Surgeons national surgical quality improvement program database
Anaissie, J, Dursun, F, Wallis, CJD, Klaassen, Z, Taylor, J, Obando-Perez, C, Xu, J, Boone, T, Khavari, R & Satkunasivam, R 2021, , International Braz J Urol, vol. 47, no. 5, pp. 1006-1019. https://doi.org/10.1590/S1677-5538.IBJU.2020.1098

Active surveillance in favorable intermediate-risk prostate cancer patients: Predictors of deferred intervention and treatment choice
Sayyid, RK, Klotz, L, Benton, JZ, Ma, M, Woodruff, P, Satkunasivam, R, Terris, MK, Wallis, CJD & Klaassen, Z 2021, , Journal of the Canadian Urological Association, vol. 16, no. 1, 7272. https://doi.org/10.5489/CUAJ.7272

Utilization and outcomes of metastasectomy for patients with metastatic urothelial cancer: An analysis of the national cancer database
Dursun, F, Mackay, A, Guzman, JCA, Wenker, E, Klaassen, Z, OMalley, P, Bhindi, B, Perez, CO, Xu, J, Roh, T, Sonpavade, G, Wallis, CJD & Satkunasivam, R 2021, , Urologic Oncology: Seminars and Original Investigations. https://doi.org/10.1016/j.urolonc.2021.07.015

Not So “Active” Surveillance
Wallis, CJD, Klotz, L, Satkunasivam, R & Klaassen, Z 2021, , International Journal of Radiation Oncology Biology Physics, vol. 110, no. 3, pp. 716-717. https://doi.org/10.1016/j.ijrobp.2021.01.030

Association between cytoreductive nephrectomy and survival among patients with metastatic renal cell carcinoma receiving modern therapies: a systematic review and meta-analysis examining effect modification according to systemic therapy approach
Hall, ME, Bhindi, B, Luckenbaugh, AN, Laviana, AA, Moses, KA, Satkunasivam, R, Rini, B, Klaassen, Z & Wallis, CJD 2021, , Cancer Causes and Control, vol. 32, no. 7, pp. 675-680. https://doi.org/10.1007/s10552-021-01435-z

Utilization and outcomes of metastasectomy for patients with metastatic urothelial cancer: An analysis of the national cancer database
Dursun, F, Mackay, A, Guzman, JCA, Wenker, E, Klaassen, Z, OMalley, P, Bhindi, B, Perez, CO, Xu, J, Roh, T, Sonpavade, G, Wallis, CJD & Satkunasivam, R 2021, , Urologic Oncology: Seminars and Original Investigations, vol. 40, no. 2, pp. 61.e21-61.e28. https://doi.org/10.1016/j.urolonc.2021.07.015

Association between prior nephrectomy and efficacy of immune checkpoint inhibitor therapy in metastatic renal cell carcinoma - A systematic review and meta-analysis
Satkunasivam, R, Guzman, JCA, Klaassen, Z, Hall, ME, Luckenbaugh, AN, Lim, K, Laviana, AA, DeRosa, AP, Beckermann, KE, Rini, B & Wallis, CJD 2022, , Urologic Oncology: Seminars and Original Investigations, vol. 40, no. 2, pp. 64.e17-64.e24. https://doi.org/10.1016/j.urolonc.2021.09.009

Association of Surgeon-Patient Sex Concordance with Postoperative Outcomes
Wallis, CJD, Jerath, A, Coburn, N, Klaassen, Z, Luckenbaugh, AN, Magee, DE, Hird, AE, Armstrong, K, Ravi, B, Esnaola, NF, Guzman, JCA, Bass, B, Detsky, AS & Satkunasivam, R 2022, , JAMA Surgery, vol. 157, no. 2, pp. 146-156. https://doi.org/10.1001/jamasurg.2021.6339

532 nm green-light laser vaporization of upper tract urothelial carcinoma
Dursun, F, Pan, MM, Morgan, M, Gonzalez, RR & Satkunasivam, R 2020, , BMC Urology, vol. 20, no. 1, 172. https://doi.org/10.1186/s12894-020-00744-w

A Systematic Review and Network Meta-analysis of Novel Androgen Receptor Inhibitors in Non-metastatic Castration-resistant Prostate Cancer
Hird, AE, Magee, DE, Bhindi, B, Ye, XY, Chandrasekar, T, Goldberg, H, Klotz, L, Fleshner, N, Satkunasivam, R, Klaassen, Z & Wallis, CJD 2020, , Clinical Genitourinary Cancer, vol. 18, no. 5, pp. 343-350. https://doi.org/10.1016/j.clgc.2020.02.005

Uretero-Iliac artery fistula: A rare cause of haematuria
Hernandez, N, Desroches, B, Peden, E & Satkunasivam, R 2020, , BMJ Case Reports, vol. 13, no. 9, e232189. https://doi.org/10.1136/bcr-2019-232189